Display options
Cite
Dogaru D, Motiu S, Gogonea V. Residue Mutations in [Fe-Fe]-hydrogenase Impedes O(2) Binding: A QM/MM Investigation. Int J Quantum Chem. 2009;110(9):1784-1792doi: 10.1002/qua.22331.
Dogaru, D., Motiu, S., & Gogonea, V. (2009). Residue Mutations in [Fe-Fe]-hydrogenase Impedes O(2) Binding: A QM/MM Investigation. International journal of quantum chemistry, 110(9), 1784-1792. https://doi.org/10.1002/qua.22331
Dogaru, Daniela, et al. "Residue Mutations in [Fe-Fe]-hydrogenase Impedes O(2) Binding: A QM/MM Investigation." International journal of quantum chemistry vol. 110,9 (2009): 1784-1792. doi: https://doi.org/10.1002/qua.22331
Dogaru D, Motiu S, Gogonea V. Residue Mutations in [Fe-Fe]-hydrogenase Impedes O(2) Binding: A QM/MM Investigation. Int J Quantum Chem. 2009 Oct 22;110(9):1784-1792. doi: 10.1002/qua.22331. PMID: 20485511; PMCID: PMC2872501.
Copy Download .nbib Format: NLM
Share it on

Int J Quantum Chem. 2009 Oct 22;110(9):1784-1792. doi: 10.1002/qua.22331.

Residue Mutations in [Fe-Fe]-hydrogenase Impedes O(2) Binding: A QM/MM Investigation.

International journal of quantum chemistry

Daniela Dogaru, Stefan Motiu, Valentin Gogonea

Affiliations

  1. Department of Chemistry, Cleveland State University, 2121 Euclid Avenue, Cleveland, Ohio 44115.

PMID: 20485511 PMCID: PMC2872501 DOI: 10.1002/qua.22331

Abstract

[Fe-Fe]-hydrogenases are enzymes that reversibly catalyze the reaction of protons and electrons to molecular hydrogen, which occurs in anaerobic media. In living systems, [Fe-Fe]-hydrogenases are mostly used for H(2) production. The [Fe-Fe]-hydrogenase H-cluster is the active site, which contains two iron atoms. The latest theoretical investigations1,2 advocate that the structure of di-iron air inhibited species are either Fe(p) (II)-Fe(d) (II)-O-H(-), or Fe(p) (II)-Fe(d) (II)-O-O-H, thus O(2) has to be prevented from binding to Fe(d) in all di-iron subcluster oxidation states in order to retain a catalytically active enzyme. By performing residue mutations on [Fe-Fe]-hydrogenases, we were able to weaken O(2) binding to distal iron (Fe(d)) of Desulfovibrio desulfuricans hydrogenase (DdH). Individual residue deletions were carried out in the 8 A apoenzyme layer radial outward from Fe(d) to determine what residue substitutions should be made to weaken O(2) binding. Residue deletions and substitutions were performed for three di-iron subcluster oxidation states, Fe(p) (II)-Fe(d) (II), Fe(p) (II)-Fe(d) (I), and Fe(p) (I)-Fe(d) (I) of [Fe-Fe]-hydrogenase. Two deletions (DeltaThr(152) and DeltaSer(202)) were found most effective in weakening O(2) binding to Fe(d) in Fe(p) (II)-Fe(d) (I) hydrogenase (DeltaG(QM/MM) = +5.4 kcal/mol). An increase in Gibbs' energy (+2.2 kcal/mol and +4.4 kcal/mol) has also been found for Fe(p) (II)-Fe(d) (II), and Fe(p) (I)-Fe(d) (I) hydrogenase respectively. pi-backdonation considerations for frontier molecular orbital and geometrical analysis corroborate the Gibbs's energy results.

References

  1. J Biol Chem. 1987 Jan 5;262(1):38-41 - PubMed
  2. J Biol Chem. 1984 Jun 10;259(11):7045-55 - PubMed
  3. Plant Physiol. 2000 Jan;122(1):127-36 - PubMed
  4. Inorg Chem. 2007 Sep 3;46(18):7256-8 - PubMed
  5. Nature. 1997 Jan 9;385(6612):126 - PubMed
  6. Chem Soc Rev. 2003 Sep;32(5):268-75 - PubMed
  7. Science. 1998 Dec 4;282(5395):1853-8 - PubMed
  8. Eur J Biochem. 1992 Oct 1;209(1):63-72 - PubMed
  9. Inorg Chem. 2004 Jun 14;43(12):3733-41 - PubMed
  10. Biotechnol Bioeng. 2000 Apr 5;68(1):1-10 - PubMed
  11. J Biol Chem. 1987 Nov 5;262(31):15054-61 - PubMed
  12. Science. 1998 Dec 4;282(5395):1842-3 - PubMed
  13. Structure. 1999 Jan 15;7(1):13-23 - PubMed
  14. Phys Rev B Condens Matter. 1988 Jan 15;37(2):785-789 - PubMed
  15. Trends Biochem Sci. 2002 Mar;27(3):148-53 - PubMed
  16. Chemistry. 2007;13(25):7075-84 - PubMed
  17. Chemistry. 2005 Jan 7;11(2):509-20 - PubMed
  18. J Am Chem Soc. 2004 Dec 29;126(51):16988-99 - PubMed
  19. Inorg Chem. 2007 Feb 19;46(4):1153-61 - PubMed
  20. J Biol Chem. 1989 Dec 15;264(35):20974-83 - PubMed
  21. Biochemistry. 2002 Feb 12;41(6):2036-43 - PubMed
  22. Inorg Chem. 2004 Jan 12;43(1):14-26 - PubMed
  23. FEMS Microbiol Rev. 2001 Aug;25(4):455-501 - PubMed
  24. Biochim Biophys Acta. 1990 Nov 5;1020(2):115-45 - PubMed
  25. J Am Chem Soc. 2001 Apr 25;123(16):3734-42 - PubMed
  26. Curr Opin Struct Biol. 1999 Dec;9(6):670-6 - PubMed
  27. J Am Chem Soc. 2001 Apr 25;123(16):3828-9 - PubMed
  28. J Am Chem Soc. 2002 May 8;124(18):5175-82 - PubMed
  29. J Biol Inorg Chem. 2004 Jul;9(5):636-42 - PubMed
  30. Inorg Chem. 2007 Jan 22;46(2):384-94 - PubMed
  31. J Biol Chem. 1988 Dec 15;263(35):18732-8 - PubMed
  32. Curr Opin Chem Biol. 2004 Apr;8(2):133-40 - PubMed
  33. Inorg Chem. 2007 Jan 8;46(1):108-16 - PubMed
  34. Inorg Chem. 2008 Apr 7;47(7):2380-8 - PubMed
  35. J Inorg Biochem. 2002 Jul 25;91(1):1-8 - PubMed
  36. Inorg Chem. 2002 Mar 25;41(6):1421-9 - PubMed
  37. Inorg Chem. 2003 Jul 28;42(15):4773-81 - PubMed
  38. Biochim Biophys Acta. 1994 Dec 30;1188(3):167-204 - PubMed
  39. Inorg Chem. 2007 Jul 23;46(15):5911-21 - PubMed
  40. Angew Chem Int Ed Engl. 1999 Nov 2;38(21):3178-3180 - PubMed
  41. Int J Quantum Chem. 2009 Mar 15;109(4):876-889 - PubMed

Publication Types

Grant support